Novo Nordisk Pharma AG
http://www.novonordisk.ch
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Novo Nordisk Pharma AG
Digital Tech Convergence Is Transforming Health Care - LSX Panel
Leaders from Eli Lilly and Vertex Pharmaceuticals, 9amHealth, Features Capital, and accelerator PharmStars discussed the convergence of biopharma, medtech and healthtech, and what is needed to achieve health care transformation, in an LSX World Congress USA panel.
Rivus Gets A Muscle-Sparing Heart Failure Hit
But competing with the likes of Wegovy and Zepbound will be a big ask.
One In Five English HTAs Terminated Due To Company Non-Submissions And Withdrawals
Since 2019, 91 health technology assessments have been terminated by England’s NICE because companies withdrew their applications or did not submit evidence. In the first of this three-part article series, pharma firms share their reasons for opting out of the process.
Why US Payers Aren’t Reimbursing Obesity Meds
Payers are restricting access to obesity drugs due to huge patient numbers and a wave of innovation in other areas
Company Information
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice